Investigation of the structural requirements for the kappa-selective opioid receptor antagonist, 6 beta,6 beta'-[ethylenebis(oxyethyleneimino)]bis[17-(cyclopropylmethyl)- 4,5 alpha-epoxymorphinan-3,14-diol] (TENA). [electronic resource]
- Journal of medicinal chemistry May 1986
- 874-6 p. digital
Publication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.